» Authors » Rongqiang Zhuang

Rongqiang Zhuang

Explore the profile of Rongqiang Zhuang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 357
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang Y, Sun Y, Zeng X, Zhuang R, Huang J, Zhang X, et al.
J Med Chem . 2024 Jan; 67(3):2165-2175. PMID: 38270637
TMTP1 (NVVRQ) has been proven to selectively target various highly metastatic tumor cells. Nonetheless, existing TMTP1 probes encounter challenges such as rapid blood clearance, limited tumor uptake, and inadequate suitability...
12.
Wen X, Zeng X, Liu J, Zeng X, Zhang Y, Cheng X, et al.
Bioconjug Chem . 2023 Dec; 34(12):2387-2397. PMID: 38055912
The objective of this study is to compare a series of albumin-based folate radiotracers for the potential imaging of folate receptor (FR) positive macrophages in advanced atherosclerotic plaques. Diversified radioiodinated...
13.
Liu H, Sun Y, Li J, Chen Y, Liu J, Fang J, et al.
Mol Pharm . 2023 May; 20(7):3529-3538. PMID: 37243620
The stimulator of interferon genes (STING) is a pivotal protein in the production of STING-dependent type I interferon, which has the potential to enhance tumor rejection. The visualization of STING...
14.
Wang T, Xu P, Fang J, Li C, Zeng X, Liu J, et al.
Mol Pharm . 2022 Dec; 20(2):1015-1024. PMID: 36562303
Benzamide (BZA), a small molecule that can freely cross cell membranes and bind to melanin, has served as an effective targeting group for melanoma theranostics. In this study, a novel...
15.
Zhang Y, Li J, Liu C, Zheng K, Zhang B, Zhou Y, et al.
Opt Express . 2022 Oct; 30(20):35854-35870. PMID: 36258527
Optical coherence tomography angiography (OCTA) images suffer from inevitable micromotion (breathing, heartbeat, and blinking) noise. These image artifacts can severely disturb the visibility of results and reduce accuracy of vessel...
16.
Wen X, Zeng X, Liu J, Zhang Y, Shi C, Wu X, et al.
Bioconjug Chem . 2022 Oct; 33(11):2170-2179. PMID: 36256849
We put forward a novel targeting-triggering-therapy (TTT) scheme that combines Cu-based targeted radionuclide therapy (TRT) with programmed death-ligand 1 (PD-L1)-based immunotherapy for enhancing therapeutic efficacy. The αβ integrin-targeted Cu-DOTA-EB-cRGDfK (Cu-DER)...
17.
Fang J, Feng L, Meng L, Wang X, Liu H, Huang L, et al.
Eur J Nucl Med Mol Imaging . 2022 Sep; 50(1):27-37. PMID: 36066666
Purpose: Stimulator of interferon genes (STING) protein plays a vital role in the immune surveillance of tumor microenvironment. Monitoring STING expression in tumors benefits the relevant STING therapy. This study...
18.
Feng L, Fang J, Zeng X, Liu H, Zhang J, Huang L, et al.
ACS Omega . 2022 Aug; 7(32):28597-28604. PMID: 35990434
This study aims to develop a novel Ga-labeled tracer, which can covalently bind to albumin in vivo based on the maleimide-thiol strategy, and to evaluate its potential applications using positron...
19.
Li J, Chen Y, Peng C, Hong X, Liu H, Fang J, et al.
ACS Chem Neurosci . 2022 Jun; 13(13):1966-1973. PMID: 35758284
Riboflavin transporter-3 (RFVT3) is a recently discovered and novel biomarker for the theranostics of nervous system diseases. RFVT3 is significantly overexpressed in cerebral injury after ischemic stroke. Herein, we first...
20.
Meng L, Fang J, Zhao L, Wang T, Yuan P, Zhao Z, et al.
J Med Chem . 2022 Jun; 65(12):8245-8257. PMID: 35658448
The fibroblast activation protein (FAP), overexpressed on cancer-associated fibroblasts (CAFs), has become a valuable target for tumor diagnosis and therapy. However, most FAP-based radioligands show insufficient tumor uptake and retention....